Hereditary Breast and Ovarian Cancer Syndrome
"Hereditary Breast and Ovarian Cancer Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autosomal dominant HEREDITARY CANCER SYNDROME in which a mutation most often in either BRCA1 or BRCA2 is associated with a significantly increased risk for breast and ovarian cancers.
| Descriptor ID |
D061325
|
| MeSH Number(s) |
C04.588.180.483 C04.588.322.455.431 C04.700.517 C13.351.500.056.630.705.431 C13.351.937.418.685.431 C16.320.700.517 C17.800.090.500.483 C19.344.410.431 C19.391.630.705.431
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hereditary Breast and Ovarian Cancer Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Hereditary Breast and Ovarian Cancer Syndrome".
This graph shows the total number of publications written about "Hereditary Breast and Ovarian Cancer Syndrome" by people in this website by year, and whether "Hereditary Breast and Ovarian Cancer Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hereditary Breast and Ovarian Cancer Syndrome" by people in Profiles.
-
Swisher EM, Aghajanian C, O'Malley DM, Fleming GF, Kaufmann SH, Levine DA, Birrer MJ, Moore KN, Spirtos NM, Shahin MS, Reid TJ, Friedlander M, Steffensen KD, Okamoto A, Sehgal V, Ansell PJ, Dinh MH, Bookman MA, Coleman RL. Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study. Gynecol Oncol. 2022 02; 164(2):245-253.
-
Schroeder C, Faust U, Sturm M, Hackmann K, Grundmann K, Harmuth F, Bosse K, Kehrer M, Benkert T, Klink B, Mackenroth L, Betcheva-Krajcir E, Wimberger P, Kast K, Heilig M, Nguyen HP, Riess O, Schr?ck E, Bauer P, Rump A. HBOC multi-gene panel testing: comparison of two sequencing centers. Breast Cancer Res Treat. 2015 Jul; 152(1):129-136.
-
Willis NA, Chandramouly G, Huang B, Kwok A, Follonier C, Deng C, Scully R. BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks. Nature. 2014 Jun 26; 510(7506):556-9.
-
Clague J, Wilhoite G, Adamson A, Bailis A, Weitzel JN, Neuhausen SL. RAD51C germline mutations in breast and ovarian cancer cases from high-risk families. PLoS One. 2011; 6(9):e25632.